Bildkälla: Stockfoto

Genovis: Strategic investment in developer of RNase inhibitors - Redeye

Redeye comments on Genovis following the announcement of a strategic investment in SEQURNA, a developer of next-generation RNase inhibitors. Similar to the market, we positively view the announcement.

Redeye comments on Genovis following the announcement of a strategic investment in SEQURNA, a developer of next-generation RNase inhibitors. Similar to the market, we positively view the announcement.
Börsvärldens nyhetsbrev
ANNONSER